DKA Calculator

Understanding Diabetic Ketoacidosis (DKA)

Diabetic ketoacidosis (DKA) is a potentially life-threatening acute metabolic complication of diabetes mellitus characterized by the triad of hyperglycemia, metabolic acidosis, and ketonemia. It occurs most commonly in type 1 diabetes but can also present in type 2 diabetes under physiological stress. Early recognition and aggressive management are critical, as untreated DKA carries a mortality rate of 5–10% even in developed healthcare systems.

Pathophysiology of DKA

DKA results from absolute or relative insulin deficiency coupled with counter-regulatory hormone excess (glucagon, cortisol, catecholamines, growth hormone). Without adequate insulin, cells cannot utilize glucose, leading to lipolysis and hepatic ketogenesis. The resulting ketoacids (beta-hydroxybutyrate, acetoacetate) overwhelm buffering capacity, producing metabolic acidosis. Osmotic diuresis from hyperglycemia causes profound dehydration and electrolyte losses.

Diagnostic Criteria and Laboratory Workup

The ADA defines DKA by three hallmark findings: blood glucose typically >250 mg/dL (though euglycemic DKA can present with lower values), arterial pH <7.30, and serum bicarbonate <18 mEq/L with positive serum or urine ketones. A complete workup includes a basic metabolic panel, arterial blood gas, serum ketones (beta-hydroxybutyrate preferred), and calculation of the anion gap and corrected sodium.

Severity Classification

Key Calculations: Anion Gap & Corrected Sodium

Evidence-Based Treatment Protocols

DKA management rests on four pillars: aggressive IV fluid resuscitation (1–1.5 L normal saline in the first hour), continuous IV insulin infusion (0.1 units/kg/hr in adults, 0.05–0.1 in pediatrics), electrolyte replacement (especially potassium before insulin if K¹ <3.3 mEq/L), and identification and treatment of the precipitating cause. Dextrose is added to IV fluids once glucose drops below 250 mg/dL to allow continued insulin infusion for ketosis resolution.

Complications of DKA

The most feared complication is cerebral edema, particularly in pediatric patients, which carries up to 25% mortality. Other complications include hypokalemia from insulin-driven intracellular potassium shift, hypoglycemia from aggressive insulin therapy, pulmonary edema from rapid fluid resuscitation, and venous thromboembolism due to dehydration-induced hypercoagulability. Non-cardiogenic pulmonary edema and rhabdomyolysis may also occur in severe cases.

Special Populations: Pediatric & Euglycemic DKA

Pediatric DKA requires cautious fluid resuscitation (not exceeding 1.5–2× maintenance) and lower insulin doses (0.05 units/kg/hr) to minimize cerebral edema risk. Euglycemic DKA (glucose <250 mg/dL) is increasingly recognized with SGLT2 inhibitor use, pregnancy, and starvation. It demands a high index of suspicion because the absence of marked hyperglycemia can delay diagnosis. SGLT2 inhibitors should be discontinued immediately in suspected cases.

DKA Prevention & Sick-Day Rules

Most DKA episodes are preventable through patient education. Key strategies include never omitting insulin (even when not eating), checking blood glucose and ketones when ill, maintaining hydration during illness, having a written sick-day management plan, and wearing medical identification. Patients on insulin pumps should check for catheter occlusion, and those on SGLT2 inhibitors should know to hold the medication during acute illness or before surgery.

How This Calculator Supports Clinical Decisions

This advanced DKA calculator integrates laboratory values, clinical parameters, and treatment history to provide real-time severity scoring, anion gap trending, corrected sodium computation, mortality risk stratification, and personalized treatment protocols aligned with ADA guidelines. It serves as a bedside decision-support tool for emergency physicians, intensivists, and endocrinologists managing acute diabetic emergencies.